Vincristine Sulfate

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
Jul 10, 1963	OncovinNDA 14103 · New molecular entity	Lilly	45	Discontinued
Jul 17, 1987	Vincasar PfsANDA 71426	Teva Parenteral	18	Discontinued
Apr 19, 1988	Vincristine Sulfate PfsANDA 71484	Hospira	27	Marketed
Jul 12, 1988	VincrexANDA 70867	Bristol Myers Squibb	2	Discontinued
Sep 1, 1999	Vincristine Sulfate PfsANDA 75493	Teva Pharms USA	8	Discontinued
Dec 20, 2002	Vincristine SulfateANDA 76296	Fresenius Kabi USA	0	Discontinued
Oct 28, 2003	Vincristine SulfateANDA 76401	Fresenius Kabi USA	0	Discontinued
Aug 9, 2012	MarqiboNDA 202497 · New formulation or manufacturer	Acrotech	10	Discontinued
—	Vincristine SulfateANDA 70411	Abraxis Pharm	0	Discontinued
—	Vincristine SulfateANDA 70777	Quad Pharms	0	Discontinued
—	Vincristine SulfateANDA 70778	Quad Pharms	0	Discontinued
—	Vincristine SulfateANDA 70873	Abic	0	Discontinued
—	Vincristine SulfateANDA 71222	Quad Pharms	0	Discontinued
—	Vincristine SulfateANDA 71223	Quad Pharms	0	Discontinued
—	Vincristine SulfateANDA 71559	Hospira	0	Discontinued
—	Vincristine SulfateANDA 71560	Hospira	0	Discontinued
—	Vincristine SulfateANDA 71561	Hospira	0	Discontinued
—	Vincristine SulfateANDA 71937	Quad Pharms	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA